Improvements in Psoriasis-Related Work Productivity with Tildrakizumab: Results from a Phase 4 Real-World Study in Patients with Moderate-to-Severe Plaque Psoriasis.

Dermatol Ther (Heidelb) · 2024 · PMC11052965 · PMID 38575729

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

The absenteeism domain score decreased from baseline to week 64 (from 1.1 ± 5.7 to 0.0 ± 0.0), but this change did not reach statistical significance (Fig. 1 d).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.